Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
44
A Quote, Financials, Valuation and Earnings
Last price:
$123.08
Seasonality move
:
2.2%
Day range:
$120.78 - $123.50
52-week range:
$117.17 - $155.35
Dividend yield:
0.78%
P/E ratio:
28.16x
P/S ratio:
5.42x
P/B ratio:
5.79x
Volume:
2M
Avg. volume:
2M
1-year change:
-16.94%
Market cap:
$34.9B
Revenue:
$6.5B
EPS (TTM):
$4.35
Analysts' Opinion
-
Consensus RatingAgilent Technologies has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $151.56, Agilent Technologies has an estimated upside of 24.09% from its current price of $122.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $135.00 representing 100% downside risk from its current price of $122.49.
Fair Value
-
According to the consensus of 16 analysts, Agilent Technologies has 24.09% upside to fair value with a price target of $151.56 per share.
A vs. S&P 500
-
Over the past 5 trading days, Agilent Technologies has underperformed the S&P 500 by -0.86% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Agilent Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Agilent Technologies has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Agilent Technologies reported revenues of $1.7B.
Earnings Growth
-
Agilent Technologies earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Agilent Technologies reported earnings per share of $1.11.
Enterprise value:
36.8B
EV / Invested capital:
3.92x
Price / LTM sales:
5.42x
EV / EBIT:
23.20x
EV / Revenue:
5.64x
PEG ratio (5yr expected):
7.88x
EV / Free cash flow:
28.06x
Price / Operating cash flow:
26.98x
Enterprise value / EBITDA:
19.86x
Gross Profit (TTM):
$3.5B
Return On Assets:
11.13%
Net Income Margin (TTM):
19.27%
Return On Equity:
20.82%
Return On Invested Capital:
13.98%
Operating Margin:
22.37%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $6.9B | $6.7B | $6.5B | $1.7B | $1.7B | |
| Gross Profit | $3.8B | $3.4B | $3.5B | $908M | $899M | |
| Operating Income | $1.7B | $1.3B | $1.5B | $384M | $376M | |
| EBITDA | $2B | $1.7B | $1.9B | $487M | $467M | |
| Diluted EPS | $4.43 | $4.20 | $4.35 | $1.18 | $1.11 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.5B | $3.5B | $4.1B | $4.3B | $4.1B | |
| Total Assets | $9.7B | $10.3B | $10.9B | $10.9B | $11.9B | |
| Current Liabilities | $1.7B | $1.6B | $1.9B | $1.6B | $1.9B | |
| Total Liabilities | $4.9B | $5.2B | $5.3B | $4.8B | $5.9B | |
| Total Equity | $4.8B | $5.2B | $5.6B | $6.2B | $6B | |
| Total Debt | $2.5B | $2.7B | $3B | $2.6B | $3.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $2B | $1.7B | $485M | $431M | |
| Cash From Investing | -$363M | -$301M | -$1.3B | -$95M | -$94M | |
| Cash From Financing | -$843M | -$1.2B | -$692M | -$240M | -$180M | |
| Free Cash Flow | $1.1B | $1.6B | $1.3B | $395M | $334M | |
A
Sector
Market Cap
$34.9B
$37.4M
Price % of 52-Week High
78.85%
45.61%
Dividend Yield
0.78%
0%
Shareholder Yield
3.21%
-0.75%
1-Year Price Total Return
-16.95%
-38.36%
Beta (5-Year)
1.108
0.774
Dividend yield:
0.78%
Annualized payout:
$0.94
Payout ratio:
21.92%
Growth streak:
9 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$122.71
200-day SMA
Sell
Level
$136.90
Bollinger Bands (100)
Sell
Level
128.94 - 144.36
Chaikin Money Flow
Buy
Level
504.7M
20-day SMA
Sell
Level
$128.52
Relative Strength Index (RSI14)
Sell
Level
36.02
ADX Line
Sell
Level
38.61
Williams %R
Neutral
Level
-72.4352
50-day SMA
Sell
Level
$137.93
MACD (12, 26)
Sell
Level
-5.45
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
575.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.0466)
Buy
CA Score
(Annual)
Level (0.4946)
Buy
Beneish M-Score
(Annual)
Level (-2.6377)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.3778)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Stock Forecast FAQ
In the current month, A has received 6 Buy ratings 10 Hold ratings, and 0 Sell ratings. The A average analyst price target in the past 3 months is $151.56.
-
Where Will Agilent Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Agilent Technologies share price will rise to $151.56 per share over the next 12 months.
-
What Do Analysts Say About Agilent Technologies?
Analysts are divided on their view about Agilent Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agilent Technologies is a Sell and believe this share price will drop from its current level to $135.00.
-
What Is Agilent Technologies's Price Target?
The price target for Agilent Technologies over the next 1-year time period is forecast to be $151.56 according to 16 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is A A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Agilent Technologies is a Hold. 10 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of A?
You can purchase shares of Agilent Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agilent Technologies shares.
-
What Is The Agilent Technologies Share Price Today?
Agilent Technologies was last trading at $123.08 per share. This represents the most recent stock quote for Agilent Technologies. Yesterday, Agilent Technologies closed at $122.49 per share.
-
How To Buy Agilent Technologies Stock Online?
In order to purchase Agilent Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
